MARKET RADAR
SENSEX     NIFTY      Refresh
Bafna Pharmaceuticals Nine Months, Bafna Pharmaceuticals Financial Statement & Accounts
YOU ARE HERE > MONEYCONTROL > MARKETS > Pharmaceuticals > Nine Months - Bafna Pharmaceuticals
Bafna Pharmaceuticals
BSE: 532989|NSE: BAFNAPHARM|ISIN: INE878I01014|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
May 23, 17:00
35.65
-0.5 (-1.38%)
VOLUME 9,371
LIVE
NSE
May 23, 17:00
36.15
0.3 (0.84%)
VOLUME 2,720
Download Annual Report PDF Format 2011 | 2010

Nine Months of Bafna Pharmaceuticals

------------------- in Rs. Cr. -------------------
Dec '12 Dec '11 Dec '10 Dec '09 Dec '08
Net Sales/Income from operations 116.47 88.25 71.70 50.33 28.36
Other Operating Income 3.85 -- -- -- --
Total Income From Operations 120.33 88.25 71.70 -- --
EXPENDITURE
Consumption of Raw Materials 32.46 67.40 60.13 46.21 23.67
Purchase of Traded Goods 58.49 -- -- -- --
Increase/Decrease in Stocks -3.78 -2.70 -1.69 -6.00 -0.24
Power & Fuel -- -- -- -- --
Employees Cost 7.80 4.82 2.14 1.91 1.03
Depreciation 5.39 4.83 1.72 1.32 2.30
Excise Duty -- -- -- -- --
Admin. And Selling Expenses -- -- -- -- --
R & D Expenses -- -- -- -- --
Provisions And Contingencies -- -- -- -- --
Exp. Capitalised -- -- -- -- --
Other Expenses 7.03 4.60 2.19 1.56 1.41
P/L Before Other Inc. , Int., Excpt. Items & Tax 12.94 9.30 7.21 -- --
Other Income 1.43 1.13 0.47 0.50 0.95
P/L Before Int., Excpt. Items & Tax 14.38 10.43 7.68 -- --
Interest 7.96 5.18 3.08 2.35 1.39
P/L Before Exceptional Items & Tax 6.42 5.25 4.60 -- --
Exceptional Items -- -0.38 -- -- --
P/L Before Tax 6.42 4.87 4.60 -- --
Tax 1.88 0.71 -- -- --
P/L After Tax from Ordinary Activities 4.54 4.16 4.60 -- --
Prior Year Adjustments -- -- -- -- --
Extra Ordinary Items -- -- -0.39 -0.42 -0.50
Net Profit/(Loss) For the Period 4.54 4.16 4.21 3.05 -0.76
Equity Share Capital 18.66 17.48 15.98 15.98 15.98
Reserves Excluding Revaluation Reserves -- -- -- -- --
Equity Dividend Rate (%) -- -- -- -- --
EPS Before Extra Ordinary
Basic EPS 2.43 2.38 2.63 -- --
Diluted EPS 2.43 2.38 2.63 -- --
EPS After Extra Ordinary
Basic EPS 2.43 2.38 2.63 -- --
Diluted EPS 2.43 2.38 2.63 -- --
Public Share Holding
No Of Shares (Crores) 1.16 1.03 0.81 0.79 0.81
Share Holding (%) 61.96 58.92 50.60 49.68 50.45
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of shares (Crores) 0.13 0.17 0.10 -- --
- Per. of shares (as a % of the total sh. of prom. and promoter group) 18.08 24.06 12.98 -- --
- Per. of shares (as a % of the total Share Cap. of the company) 6.88 9.88 6.41 -- --
b) Non-encumbered
- Number of shares (Crores) 0.58 0.65 0.69 -- --
- Per. of shares (as a % of the total sh. of prom. and promoter group) 81.92 75.94 87.02 -- --
- Per. of shares (as a % of the total Share Cap. of the company) 31.16 31.20 49.40 -- --
Notes
Source : Dion Global Solutions Limited
Quick Links for bafnapharmaceuticals
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.